EU to reward antibiotic innovation with new pharma rules

Drugmakers that develop new antibiotics are set to benefit from longer market protection in Europe after the EU agreed Thursday to a wide-ranging reform of pharmaceutical rules seeking to boost innovation and tackle antimicrobial resistance.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup